SEC FORM
3
SEC Form 3
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0104 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year)
10/29/2018
|
3. Issuer Name and Ticker or Trading Symbol
ORASURE TECHNOLOGIES INC
[ OSUR ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
|
10% Owner |
| X |
Officer (give title below) |
|
Other (specify below) |
| VP, Finance and Controller |
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Beneficially Owned |
|---|
| 1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Common Stock |
1,573 |
D |
|
| Common Stock |
1,130
|
D |
|
| Common Stock |
1,288
|
D |
|
| Common Stock |
974
|
D |
|
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Non-Qualified Stock Options |
|
02/03/2024 |
Common Stock |
1,758 |
5.71 |
D |
|
| Non-Qualified Stock Options |
|
02/03/2025 |
Common Stock |
2,362 |
9.31 |
D |
|
| Non-Qualified Stock Options |
|
02/01/2026 |
Common Stock |
7,140 |
5.37 |
D |
|
| Non-Qualified Stock Options |
|
02/01/2027 |
Common Stock |
6,091 |
8.87 |
D |
|
| Non-Qualified Stock Options |
|
02/01/2028 |
Common Stock |
3,254 |
21.65 |
D |
|
| Explanation of Responses: |
|
|
|
|
|
|
|
|
| Remarks: |
|
|
/s/ Jack E. Jerrett As Attorney-In-Fact For Michele Marie Miller |
11/02/2018 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
POWER OF ATTORNEY
Know all by these presents, that each person whose signature appears
below hereby designates and appoints each of Roberto Cuca, Jack E. Jerrett and
Michele Miller, signing singly, the undersigned's true and lawful attorney-in-
fact to: (1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of OraSure Technologies, Inc. (the
"Company"), Forms 3, 4, and 5, and any amendments or supplements to such Forms,
in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the
rules thereunder; (2) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and execute any such
Form 3, 4, and 5, or amendments or supplements thereto, and timely file such
Forms, amendments and supplements with the United States Securities Exchange and
Commission and any stock exchange or similar authority; and (3) take any other
action of any type whatsoever in connection with the foregoing which, in the
opinion of such attorney-in-fact, may be in the best interest of, or legally
required by, the undersigned, it being understood that the documents executed by
such attorney-in-fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and conditions as
such attorney-in-fact may approve.
The undersigned hereby grants to each attorney-in-fact full power and
authority to take any action whatsoever requisite, necessary, or proper to be
done in the exercise of any of the rights and powers herein granted, as fully to
all intents and purposes as the undersigned might or could do if personally
present, with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or his or her substitute, shall
lawfully do or cause to be done by virtue of this Power of Attorney. The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, and of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934 or the rules thereunder.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact or the Company. By executing this Power of Attorney,
the undersigned hereby revoked all prior powers of attorney executed by the
undersigned with respect to the execution of Forms 3, 4, and 5 with respect to
the undersigned's holdings of and transactions in securities issued by the
Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 10 day of October, 2018
/s/Michele M. Miller
----------------------
Signature
Michele M. Miller
---------------------
Print name
